In July 1997, Novartis filed a fresh patent application in Switzerland around the beta crystalline sort of imatinib mesylate (the mesylate salt of imatinib). The "beta crystalline sort" of your molecule is a specific https://tasneemmegq408546.mpeblog.com/60771433/new-step-by-step-map-for-スプリセル-ダサチニブ